GEND Short Volume
Genter Capital Dividend Income ETF (GEND) operates in the Financial Services sector, specifically the Asset Management - Income industry, with a market capitalization near $3.4M, listed on AMEX, carrying a beta of 0.37 to the broader market. Under typical market conditions, the Genter Capital Dividend Income ETF (GEND) primarily focuses its investments by allocating a minimum of 80% of its total assets, including any funds obtained through borrowing, to equity securities of U. public since 2024-12-27.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-28
- Short Volume
- 5
- Total Volume
- 510
- Short %
- 0.98%
- 30-Day Avg Short %
- 55.98%
Showing 30 days of FINRA short volume data for Genter Capital Dividend Income ETF.
Learn how short volume is reported and how to read the data →
Frequently asked GEND short volume questions
- What is the daily GEND short volume?
- As of Aug 28, 2026, Genter Capital Dividend Income ETF (GEND) short volume is 5 shares against 510 total reported volume, or 0.98% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is GEND short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does GEND short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.